Table 2 |
||||||||
| HIV-1 subtypes and distribution of resistance-associated mutations among 19 ART-naïve patients attending three health centers in Djibouti city between October and December 2009 | ||||||||
| Patients | SEX | CD4 | VL (cp/mL) | SUBTYPE | NRTI | NNRTI | Major Mutation PI | Minor Mutation PI |
| 1 | M | 208 | 170 000 | C | None | None | None | None |
| 2 | M | 107 | 4 690 000 | C | None | None | None | None |
| 3 | F | 186 | 1 600 000 | CRFO2_AG | None | K103N | None | None |
| 4 | M | 167 | 150 000 | C | None | None | None | None |
| 5 | F | 195 | 160 000 | C | None | None | None | None |
| 6 | F | 154 | 98 000 | C | None | None | None | None |
| 7 | F | 104 | 3 360 | CRF02_AG | None | None | None | None |
| 8 | F | 47 | 350 000 | C | None | K101Q, K103N | None | None |
| 9 | M | 126 | 76 000 | CRFO2_AG | None | None | None | L10V |
| 10 | M | 100 | 150 000 | C | None | None | None | None |
| 11 | M | 20 | 420 000 | CRF02_AG | None | None | None | None |
| 12 | F | 51 | 45 000 | K/C | None | None | None | None |
| 13 | F | 540 | 260 000 | C | None | None | None | None |
| 14 | M | 56 | 43 900 | C | None | None | None | None |
| 15 | F | 23 | 663 000 | C | None | None | None | None |
| 16 | M | 49 | 185 000 | C | None | None | None | None |
| 17 | F | 170 | 87 200 | B | None | K101E | None | None |
| 18 | F | 250 | 120 000 | C | None | None | None | None |
| 19 | F | 90 | 431 000 | C | None | None | None | None |
Elmi Abar et al. Diagnostic Pathology 2012 7:138 doi:10.1186/1746-1596-7-138
